nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
|
Nanthapisal, Sira |
|
|
40 |
18 |
p. 2551-2560 |
artikel |
2 |
Cross-protection induced by highly conserved outer membrane proteins (Omps) in mice immunized with OmpC of Salmonella Typhi or OmpK36 of Klebsiella pneumoniae
|
Liu, Esther Yip-Mei |
|
|
40 |
18 |
p. 2604-2611 |
artikel |
3 |
Decreasing routine vaccination rates in children in the COVID-19 era
|
Maltezou, Helena C. |
|
|
40 |
18 |
p. 2525-2527 |
artikel |
4 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
18 |
p. IFC |
artikel |
5 |
Effectiveness of the Comirnaty and the Vaxzevria vaccines in preventing SARS-CoV-2 infection among residents in Lazio region (Italy)
|
Fano, Valeria |
|
|
40 |
18 |
p. 2540-2545 |
artikel |
6 |
Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study
|
St Jean, Denise T. |
|
|
40 |
18 |
p. 2580-2587 |
artikel |
7 |
Efficacy and safety of a quadrivalent influenza vaccine in children aged 6–35 months: A global, multiseasonal, controlled, randomized Phase III study
|
Esposito, Susanna |
|
|
40 |
18 |
p. 2626-2634 |
artikel |
8 |
Healthcare worker perspectives on COVID-19 vaccines: Implications for increasing vaccine acceptance among healthcare workers and patients
|
Thomas, Christine M. |
|
|
40 |
18 |
p. 2612-2618 |
artikel |
9 |
IgA nephropathy in a pediatric patient after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine
|
Abdel-Qader, Derar H. |
|
|
40 |
18 |
p. 2528-2530 |
artikel |
10 |
IgG antibody production and persistence to 6 months following SARS-CoV-2 vaccination: A Northern Ireland observational study
|
Robertson, Louise J. |
|
|
40 |
18 |
p. 2535-2539 |
artikel |
11 |
Imperfect messengers? An analysis of vaccine confidence among primary care physicians
|
Callaghan, Timothy |
|
|
40 |
18 |
p. 2588-2603 |
artikel |
12 |
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay
|
LeBlanc, Jason J. |
|
|
40 |
18 |
p. 2635-2646 |
artikel |
13 |
Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders
|
Zerbo, Ousseny |
|
|
40 |
18 |
p. 2568-2573 |
artikel |
14 |
SARS-CoV-2 outbreak in a nursing home after vaccination with BNT162b2: A role for the quantification of circulating antibodies
|
Càmara, Jordi |
|
|
40 |
18 |
p. 2531-2534 |
artikel |
15 |
SIRVA (Shoulder Injury Related to Vaccine Administration) following mRNA COVID-19 Vaccination: Case discussion and literature review
|
Yuen, Wen Loong Paul |
|
|
40 |
18 |
p. 2546-2550 |
artikel |
16 |
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
|
Bilgin, Huseyin |
|
|
40 |
18 |
p. 2619-2625 |
artikel |
17 |
Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005–2021
|
Liu, Xiaoxue |
|
|
40 |
18 |
p. 2561-2567 |
artikel |
18 |
Waning effectiveness of CoronaVac in real life: A retrospective cohort study in health care workers
|
Can, Gunay |
|
|
40 |
18 |
p. 2574-2579 |
artikel |